Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  PROLOR Biotech Inc    PBTH

No quotes available
-- USD   0.00%
2013 PROLOR BIOTECH : PROLOR Biotech to Present Positive Results From Pr..
2013 PROLOR BIOTECH : PROLOR Biotech To Present New Data On Its Long-Act..
2013 PROLOR BIOTECH : PROLOR Biotech To Present At Jefferies 2013 Global..
SummaryQuotesNewsCompany 
News SummaryMost relevantAll newsSector news 

PROLOR Biotech Inc : Free Research Reports on ALB, PBTH, RATE and WFR Issued by the Bedford Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/16/2013 | 05:10pm CEST

NEW YORK, NY -- (Marketwire) -- 02/14/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Albemarle Corporation(ALB) shares spiked 5 percent on twice the average daily volume Wednesday. The company's Board of Directors has approved a 20 percent increase in the company's quarterly dividend to $0.24 per share.

Find out more about Albemarle including full access to the free equity report at: www.BedfordReport.com/ALB

PROLOR Biotech Inc.(PBTH) shares gained 3 percent on more than double the average daily volume Wednesday. The company announced that its longer-acting version of human growth hormone has received orphan drug designation in Europe.

Find out more about PROLOR Biotech including full access to the free equity report at: www.BedfordReport.com/PBTH

Bankrate Inc.(RATE) shares plunged over 17 percent on nearly 5 million shares traded Wednesday. The company reported net income in the fourth quarter declined to $0.3 million, compared to a net income of $14 million a year ago.

Find out more about Bankrate including full access to the free equity report at: www.BedfordReport.com/RATE

MEMC Electronic Materials, Inc.(WFR) shares spiked 5 percent on nearly 8 million shares traded Wednesday after reporting results for the fourth quarter that topped expectations. The company reported a net loss of $11.8 million in the fourth quarter, compared to a net loss of $1.48 billion a year ago.

Find out more about MEMC Electronic Materials including full access to the free equity report at: www.BedfordReport.com/WFR

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PROLOR BIOTECH INC
2013 PROLOR BIOTECH INC : PROLOR Biotech to Present Positive Results From Preclinical..
2013 PROLOR BIOTECH INC : PROLOR Biotech To Present New Data On Its Long-Acting Human..
2013 PROLOR BIOTECH INC : PROLOR Biotech To Present At Jefferies 2013 Global Healthca..
2013 PROLOR BIOTECH INC : PROLOR Biotech, Inc. Shareholder Alert: Briscoe Law Firm an..
2013 PROLOR BIOTECH INC : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investig..
2013 PROLOR BIOTECH INC : Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Bi..
2013 PROLOR BIOTECH INC : Law Office of Brodsky & Smith, LLC Announces Investigation ..
2013 PROLOR BIOTECH INC : Law Firm Kirby McInerney LLP Investigating Potential Claims..
2013 PROLOR BIOTECH INC : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investig..
2013 PROLOR BIOTECH INC : Ryan & Maniskas, LLP Announces Investigation of PROLOR Biot..
More news
Sector news : Biotechnology & Medical Research - NEC
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12DJJuno to Resume Clinical Trial of Anticancer Treatment
07/09DJCorrections & Amplifications -- WSJ
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From -2-
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Sector and Competitors
1st jan.Capitalization (M$)
PROLOR BIOTECH INC0.00%0
INCYTE CORPORATION-20.32%16 212
CELLTRION, INC.--.--%10 689
LONZA GROUP AG11.40%9 737
QUINTILES TRANSNATIONA..7.82%8 859
ALKERMES PLC-37.26%7 528
More Results